Double-digit gains for its Digestive Health category helped Bayer Consumer Health record a 5.3% rise in adjusted second-quarter sales to €1.46bn ($1.59bn).
Introducing German brand Iberogast to the US was key to the 14.5% adjusted sales growth recorded by Digestive Health in Q2, with Bayer Consumer’s CFO Magnus Schellnock describing the roll...